Prospective Registry of Outcomes, Treatment, and Clinical Trajectories for Anti–IFN-γ Immunodeficiency - Top-Institutions - MDSpire

Prospective Registry of Outcomes, Treatment, and Clinical Trajectories for Anti–IFN-γ Immunodeficiency

  • By

  • Valerie Chiang

  • Freya Kit Lam Chung

  • Nga Yi Leung

  • Wai Ki Ip

  • Gordon Kwok Ho Chu

  • James Kwong Yew Hooi

  • Jane Chi Yan Wong

  • Elaine Yuen Ling Au

  • Philip Hei Li

  • July 15, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Queen Mary Hospital
    Queen Mary Hospital

    Hong Kong, Hong Kong

    Key Differentiators

    • Immunology

  • #2

    University of Hong Kong
    University of Hong Kong

    Hong Kong, Hong Kong

    Key Differentiators

    • Immunology

  • #3

    Hospital Authority Hong Kong West Cluster
    Hospital Authority Hong Kong West Cluster

    Hong Kong, Hong Kong

    Key Differentiators

    • Immunology

  • #4

    CorEvitas RA registry
    CorEvitas RA registry

    Multiple Locations, US

    Key Differentiators

    • Rheumatology

  • #5

    University of California at San Francisco
    University of California at San Francisco

    San Francisco, California

    Key Differentiators

    • Immunology

Original Source(s)

Prospective Registry of Outcomes, Treatment, and Clinical Trajectories for Anti–IFN-γ Immunodeficiency

  • by Valerie Chiang, Freya Kit Lam Chung, Nga Yi Leung, Wai Ki Ip, Gordon Kwok Ho Chu, James Kwong Yew Hooi, Jane Chi Yan Wong, Elaine Yuen Ling Au, Philip Hei Li

  • July 15, 2026

Related Content

Cassidy grills Trump nominee on past vaccine comments in heated exchange

Interactions between betaine, insulin resistance, and cognitive impairment in people with and without HIV

Repeated aminoglycoside exposure activates interferon-stimulated genes in human renal proximal tubular models